Last deal

$12M

Amount

Venture - Series Unknown

Stage

13.06.2017

Date

1

all rounds

$12M

Total amount

date founded

Financing round

General

About Company
Caliber Therapeutics develops stent-free drug delivery products for atherosclerotic diseases.

Industry

Sector :

Subsector :

founded date

01.01.2005

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

The company's Targeted Angioplasty Drug Delivery balloon offers controlled and targeted drug delivery, reducing thrombosis risk and the need for permanent devices. This allows patients to begin treatment more quickly and increases the likelihood of successful treatment. Caliber Therapeutics aims to provide effective treatment for vascular diseases through its proprietary drug-delivery products.
Similar Companies
1000
Aegis Therapeutics

Aegis Therapeutics

Aegis Therapeutics commercializes drug delivery and formulation technologies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Pharmaceuticals, Health Care

Location

San Diego, CA, USA
Novilla Pharmaceuticals

Novilla Pharmaceuticals

Novilla Pharmaceuticals develops drug delivery mechanisms for deeper penetration of established therapies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Arlington, VA, USA

total rounds

1
Re-Vana Therapeutics

Re-Vana Therapeutics

Re-Vana Therapeutics develops long-acting, biodegradable drug delivery platforms for chronic eye diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Biotechnology, Medical

Location

Belfast, UK

total rounds

4

total raised

$16.91M
Halozyme Therapeutics

Halozyme Therapeutics

Halozyme Therapeutics develops and sells products for insulin, cancer, dermatology, and drug delivery.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

San Diego, CA, USA

total rounds

7

total raised

$1.45B

Financials

Funding Rounds
1
1

Number of Funding Rounds

$12M

Money Raised

Their latest funding was raised on 13.06.2017. Their latest investor SternAegis. Their latest round Venture - Series Unknown

Date 
Funding Round 
Investors 
Money Raised 
Lead 
13.06.2017
1
$12M
Co-Investors
Investors
1
0

Number of lead investors

1

Number of investors

Investor 
Lead 
Round 
Partners 
No
Venture - Series Unknown
SternAegis

SternAegis

Aegis Ventures is a corporate venture arm of Aegis Capital that invests in technology, telecom, media, and emerging growth sectors.

Sector

Investment Banking and Brokerage Services

Subsector

Asset Managers and Custodians

Location

New York, NY, USA

count Of Investments

47

count Of Exists

5

People

Founders
1

Bill Baumbach

current job

Caliber Therapeutics
Caliber Therapeutics

organization founded

1

Bill Baumbach

Employee Profiles
2
Paul Geudens

Paul Geudens

VICE PRESIDENT OPERATIONS

Bill Baumbach

CSO

Activity

Recent News
0